HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anke Penno Selected Research

Hereditary Sensory and Autonomic Neuropathies (HSAN)

1/20211-Deoxysphingolipids cause autophagosome and lysosome accumulation and trigger NLRP3 inflammasome activation.
1/2017Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction.
12/2011Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
6/2011Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I.
10/2010Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I.
4/2010Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
11/2009Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
4/2009A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anke Penno Research Topics

Disease

8Hereditary Sensory and Autonomic Neuropathies (HSAN)
01/2021 - 04/2009
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2017
1Sandhoff Disease (Sandhoff's Disease)
01/2020
1Male Infertility (Male Sterility)
01/2017
1Gaucher Disease (Gaucher's Disease)
01/2017
1Starvation
03/2013
1Peripheral Nervous System Diseases (PNS Diseases)
12/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2009

Drug/Important Bio-Agent (IBA)

5Serine C-PalmitoyltransferaseIBA
01/2021 - 04/2009
5SphingolipidsIBA
01/2021 - 04/2010
3EnzymesIBA
01/2020 - 10/2010
2LipidsIBA
01/2017 - 03/2013
2Serine (L-Serine)FDA Link
12/2011 - 04/2009
1NLR ProteinsIBA
01/2021
1Alkynes (Acetylenes)IBA
01/2021
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2021
1dihydroceramide desaturaseIBA
01/2021
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2021
1safingol (sphinganine)IBA
01/2021
1fumonisin B1IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1PTEN-induced putative kinaseIBA
01/2021
1LipopolysaccharidesIBA
01/2021
1Hexosaminidases (Hexosaminidase)IBA
01/2020
1GangliosidesIBA
01/2020
1GlucosidasesIBA
01/2017
1SphingosineIBA
01/2017
1antineoplaston A10 (A 10)IBA
12/2011
1spisulosineIBA
10/2010
1CeramidesIBA
04/2009
1Palmitoyl Coenzyme A (Palmitoyl CoA)IBA
04/2009